Nasdaq · Healthcare
STAAR SURGICAL CO (STAA)
As-reported financials and recent SEC filings for STAAR SURGICAL CO, latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$239.4M
Net income
$-80.4M
Net margin
-33.6%
Diluted EPS
$-1.62
ROE
-23.4%
P/E (TTM)
—
Market cap
$1.46B
Debt / equity
—
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $239.4M | $313.9M | $322.4M | $239.4M | $230.5M |
| Gross profit | $182.4M | $239.6M | $252.7M | $178.4M | $178.6M |
| Operating income | $-91.7M | $-12.6M | $28.1M | $43.8M | $33.3M |
| Net income | $-80.4M | $-20.2M | $21.3M | $39.7M | $27.5M |
| Diluted EPS | $-1.62 | $-0.41 | $0.43 | $0.80 | $0.56 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
S-82026-06-24
View on EDGAR →42026-06-23
View on EDGAR →42026-06-22
View on EDGAR →42026-06-22
View on EDGAR →42026-06-22
View on EDGAR →42026-06-22
View on EDGAR →42026-06-22
View on EDGAR →42026-06-22
View on EDGAR →Go deeper on STAA
Search STAAR SURGICAL CO’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.